Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2NET 1Endocrine 1

Conditions

Carcinoma, Hepatocellular 7Liver Neoplasms 2Uveal Melanoma 1Tumor Response Rate 1Neuroendocrine Tumors 1Hepatic Malignancies 1Colorectal Cancer Metastatic 1Cholangiocarcinoma 1

Interventions

Sorafenib 42Bevacizumab 26Oxaliplatin 21Radiosurgery 19Gemcitabine 17Fluorouracil 15Hepatectomy 13lenvatinib 12Radiofrequency Ablation 11Nivolumab 11Cisplatin 11Radiotherapy 10Doxorubicin 10Capecitabine 10durvalumab 9Leucovorin 9Blood Specimen Collection 9atezolizumab 8Liver Transplantation 8Everolimus 7Electroporation 7pembrolizumab 6camrelizumab 6Sunitinib 6Immunohistochemistry 6Cryosurgery 6Carboplatin 6tremelimumab 5sintilimab 5apatinib 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Liver Neoplasms × Sirtuins × Clear all
NCT01469572 2018-10-18

Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

Emory University

Phase 1 Completed
13 enrolled
EndocrineGastrointestinalNET

Liver Neoplasms, Neuroendocrine Tumors

NCT00604409 2015-09-07

Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer

Fox Chase Cancer Center

Phase 1 Completed
34 enrolled
Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡